Comments
Loading...
Protalix BioTherapeutics (AMEX:PLX) Stock, Earnings Estimates, EPS, And Revenue
Protalix BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$0.100
Quarterly Revenue Estimate
$20.21 M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$45.67 M
Analyze the earnings history of Protalix BioTherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Protalix BioTherapeutics (PLX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $0.03 | $0.06 | -50.0 % |
| Jun 2024 | 2024-08-14 | $-0.03 | $0.02 | -250.0 % |
| Mar 2024 | 2024-05-10 | $-0.06 | $-0.02 | -200.0 % |
| Dec 2023 | 2024-03-14 | $-0.07 | $-0.03 | -133.3 % |
Protalix BioTherapeutics (PLX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $17.96M | $16.26M | 10.4 % |
| Jun 2024 | 2024-08-14 | $13.47M | $12.50M | 7.79 % |
| Mar 2024 | 2024-05-10 | $3.75M | $9.20M | -59.3 % |
| Dec 2023 | 2024-03-14 | $10.49M | $5.80M | 80.8 % |
FAQ
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics (PLX) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Protalix BioTherapeutics (AMEX:PLX)?
The Actual EPS was $0.03, which missed the estimate of $0.06.
What were Protalix BioTherapeutics’s (AMEX:PLX) revenues?
The Actual Revenue was $18M, which beat the estimate of $16.3M.
Browse earnings estimates, EPS, and revenue on all stocks.